The internet is full of sweet apps, but it’s also packed with shady software. Before you install something awful, give yourself an infosec education. Here are the best tools to protect yourself out there when you’re experimenting with new programs.
Late last year, Tom Webster and I did a podcast with our six marketing predictions for 2014. Two trends I mentioned were 1) the “malignant complexity” of the web that would lead to an increase in security breaches and 2) the opportunities this would create to actually market data security as a product feature.
In an online world under attack from hackers, terrorists, and just plain old bad guys wanting to wreak havoc, the idea of hack-proof Internet data safety will have to be a product feature trumpeted by new devices, software and service providers.
My prediction is coming true … but with some unexpected consequences.
The bad guys benefit
Keeping people away from your data is not just a feature, it has also become a marketing pitch, as I forecast.
Last week, Apple announced that its new operating system for iPhones would have a new encryption system. In…
View original post 630 more words
(CNN) – Three top secret, experimental vials (of ZMapp, an experimental ebola serum/drug) stored at subzero temperatures were flown into Liberia last week in a last-ditch effort to save two American missionary workers who had contracted Ebola, according to a source familiar with details of the treatment.
The process by which the medication was made available to Brantly and Writebol is highly unusual. It may have fallen under the U.S. Food and Drug Administration’s “compassionate use” regulation, which allows access to investigational drugs outside clinical trials.
Getting approval for compassionate use is often long and laborious, but in the case of Brantly and Writebol, they received the medication within seven to 10 days of their exposure to the Ebola virus.
On July 30, the Defense Threat Reduction Agency, an arm of the military responsible for any chemical, biological, radiological, nuclear and high-yield explosive threats, allotted additional funding to MAPP Biopharmaceutical due to “promising results.” – good4utah.com